1st Med Transitions
1st Med Transitions, LLC is a privately held nationwide dental practice brokerage specializing in dental practice sales and transitions. Its stated services include valuation, confidential buyer outreach, offer management, due diligence, closing coordination, and post-close transition support.
What stands out about 1st Med Transitions
The firm publicly focuses primarily on dental practices and also lists veterinary, dermatology, plastic surgery, med spa/aesthetics, and medical practices. It describes a nationwide, digital brokerage process serving private buyers and DSO buyers, with a stated focus on larger, high-performing practices.[1][2][3][4][7]
What does 1st Med Transitions do?
1st Med Transitions, LLC is a privately held nationwide dental practice brokerage specializing in dental practice sales and transitions. The firm identifies Michael S. Furlong as Founder & CEO and lists its headquarters in Pompano Beach, Florida.[1][2]
The firm publicly offers dental practice sales and transitions, practice valuations, confidential buyer outreach, competitive offer management, private dentist sale support, DSO sale support, and dental real-estate assistance.
Its stated process includes consultation, valuation, listing and marketing, offer review, due diligence, closing, and post-close transition support.[2][3]
Owners comparing intermediaries can also review Auxo’s business broker, M&A advisor and investment bank comparison, advisor-selection guide, and M&A advisor fee guide.
What should a business owner evaluate before hiring 1st Med Transitions?
For an owner evaluating a sale, the public information establishes a seller-oriented offering built around valuation, confidential marketing, private-buyer and DSO alternatives, offer management, and transaction coordination. The firm states that it specializes in larger, high-performing practices, while the dental-practice sales page does not publish a minimum engagement threshold.
An owner should clarify engagement economics, listing renewal and termination provisions, exclusivity, any buyer- or lender-side compensation, buyer qualification procedures, licensing coverage in the relevant state, and the scope of owner transition and post-close obligations.[2][3][4][7]
What commission, minimum fee, expense reimbursement, tail, termination, and listing-renewal terms apply
Is the firm representing the seller exclusively, and can it receive compensation from buyers or lenders
What practice-size, collections, EBITDA, revenue, specialty, or geography thresholds determine engagement acceptance
What size transactions does 1st Med Transitions handle?
The firm reports a $1.69M average sale price, a $12.25M largest practice sale, and more than $575M in total transaction volume on the dental-practice sales page. It also states that its transition team specializes in larger, high-performing practices and uses EBITDA-based valuations.[2]
The firm describes support for sales to private dentists and DSO buyers. Its public services also include dental real-estate assistance and transaction coordination through closing and transition.[2][3]
Dental practices are the firm’s primary public sector focus. Its website also lists veterinary, dermatology, plastic surgery, med spa/aesthetics, and medical practices as other specialties.[4]
What does 1st Med Transitions publicly disclose about fees and engagement terms?
The official dental-practice sales page identifies sold practices by location, sale price, sale type, collections, operatories, and sold status, but does not disclose buyer or seller identities, closing dates, financing terms, or consideration structure for those examples.
The seller FAQ page does not publish a universal commission percentage, minimum fee, tail period, termination schedule, or complete engagement-fee schedule. The official dental-practice sales page also does not publish a minimum collections, EBITDA, revenue, practice-size, or specialty threshold for accepting an engagement.[2][4]
The Florida Department of Business and Professional Regulation lists 1ST MED TRANSITIONS LLC as a Real Estate Corporation, license number CQ1048342, with status Current, Active. The record gives a licensure date of April 1, 2015, and an expiration date of September 30, 2027.
The firm’s homepage states that it is a licensed real estate broker in Florida and Georgia and references Georgia broker number #80215. That homepage does not itself state the current Georgia license status, expiration date, or licensing entity details.[5][6][7]
The firm describes a fully digital marketing process, confidential buyer outreach, and listings that renew every 30 days. Its stated sales process moves through consultation, valuation, listing, offer review, due diligence, closing, and transition.[2][3]
Questions to ask before hiring 1st Med Transitions
What commission, minimum fee, expense reimbursement, tail, termination, and listing-renewal terms apply?
Is the firm representing the seller exclusively, and can it receive compensation from buyers or lenders?
What practice-size, collections, EBITDA, revenue, specialty, or geography thresholds determine engagement acceptance?
Which buyer categories and DSO or MSO groups are active for the owner's specialty?
How are buyer qualifications, financing capacity, confidentiality, and competing offers handled?
Which licensed entity and individual licensees will perform brokerage services in the owner's state?
What owner transition, non-compete, credentialing, and post-close support obligations apply?
Can the firm provide dated references or transaction-level buyer and closing information under confidentiality?
Sources & research notes
- Official website / firm overview
- Official website / firm overview
- Services / capabilities
- Industry / market focus
- Structure / regulatory context
- Structure / regulatory context
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.